MET and familial pancreatic carcinoma: Studies investigating the HGF/MET pathway have been conducted in various cancer types, including NSCLC, breast cancer, head and neck cancer, colorectal cancer, gastric cancer, pancreatic cancer, and other gastrointestinal cancers.